Back to Search
WILLIAM STUART, MD
MD
Anesthesiology Physician
NPI: 1659735652IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
64740(CT)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE
Class of 2016
Research & Publications (20)
Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production.
PMID 19487969·Shock·2010
7-preclinical
The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis.
PMID 19576199·Dev Biol·2009
7-preclinical
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
PMID 19308305·J Neurol·2009
2-rct
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.
PMID 17761550·Neurology·2007
2-rct
Health-related quality of life in multiple sclerosis: effects of natalizumab.
PMID 17696126·Ann Neurol·2007
2-rct
Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
PMID 17559719·Curr Med Res Opin·2007
6-review
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.
PMID 17438220·Neurology·2007
3-trial
Wnt/beta-catenin signaling is required for development of the exocrine pancreas.
PMID 17222338·BMC Dev Biol·2007
7-preclinical
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
PMID 16510745·N Engl J Med·2006
3-trial
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
PMID 16436649·Neurology·2006
2-rct
Do we need lipid clinics? Shifting the balance between secondary and primary care.
PMID 16259798·Ann Clin Biochem·2005
8-other
A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.
PMID 16193896·Mult Scler·2005
3-trial
Creation of estrogen resistance in vivo by transgenic overexpression of the heterogeneous nuclear ribonucleoprotein-related estrogen response element binding protein.
PMID 15976060·Endocrinology·2005
7-preclinical
An integrative review of interventions for adolescent weight loss.
PMID 15801873·J Sch Nurs·2005
1-meta
Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis.
PMID 15596732·Neurology·2004
6-review
Does immediate operation for symptomatic non-ruptured abdominal aortic aneurysm compromise outcome?
PMID 15465377·Eur J Vasc Endovasc Surg·2004
8-other
Stepped-care approach to treating MS: a managed care treatment algorithm.
PMID 15253687·J Manag Care Pharm·2004
6-review
Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management.
PMID 15253686·J Manag Care Pharm·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 263 FARMINGTON AVE
FARMINGTON, CT 06030 - Phone
- (860) 679-3600
Quick Facts
- NPI
- 1659735652
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile